73 related articles for article (PubMed ID: 23762980)
1. [Effect of hemantane on bioelectric activity of brain in mice with MPTP-induced Parkinson syndrome].
Kapitsa IG; Kokshenev II; Nerobkova LN; Val'dman EA; Voronina TA
Eksp Klin Farmakol; 2013; 76(4):3-6. PubMed ID: 23762980
[TBL] [Abstract][Full Text] [Related]
2. [Estimation of the protective effect of the novel potential antiparkinsonian agent himantane against MPTP neurotoxicity].
Val'dman EA; Nerobkova LN; Voronina TA
Eksp Klin Farmakol; 2004; 67(1):7-10. PubMed ID: 15079899
[TBL] [Abstract][Full Text] [Related]
3. [Influence of hemantane and doxycycline on MPTP-evoked behavior violations in C57BL/6 mice].
Kovalev GI; Salimov RM
Eksp Klin Farmakol; 2011; 74(5):3-5. PubMed ID: 21809690
[TBL] [Abstract][Full Text] [Related]
4. [Study of hemantane effects in rats on a model of early (premotor) stage of Parkinson's disease].
Nepoklonov AV; Kapitsa IG; Ivanova EA; Voronina TA; Val'dman EA
Eksp Klin Farmakol; 2012; 75(11):3-6. PubMed ID: 23323324
[TBL] [Abstract][Full Text] [Related]
5. [Effects of subchronic hemantane administration on dopamine and serotonin receptors in intact and MPP+-treated rat brain ex vivo].
Zimin IA; Kapitsa IG; Voronina TA; Kovalev GI
Eksp Klin Farmakol; 2010 Nov; 73(11):2-5. PubMed ID: 21254589
[TBL] [Abstract][Full Text] [Related]
6. [A comparative study of hemantane and amantadine effects on dopamine transporter expression in brain of normal and MPTP-treated C57BL/6 mice].
Zimin IA; Logvinov IO; Antipova TA; Kovalev GI
Eksp Klin Farmakol; 2011; 74(1):11-4. PubMed ID: 21476268
[TBL] [Abstract][Full Text] [Related]
7. [Effects of SV heat-resisting protein on the microglial cells in MPTP-treated mice].
Yin SM; Yu DQ; An N
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2009 Feb; 25(1):79-80, 90. PubMed ID: 21186622
[No Abstract] [Full Text] [Related]
8. [Effects of antiparkinsonian drug hemantane on the level and metabolism of biogenic monoamines in brain structures of C57BL/6 mice].
Abaimov DA; Zimin IA; Kudrin VS; Kovalev GI
Eksp Klin Farmakol; 2009; 72(1):64-7. PubMed ID: 19334515
[TBL] [Abstract][Full Text] [Related]
9. [Comparative study of neurophysiological effects of adamantane derivatives in the experimental parkinsonism model].
Katunina EA; Samoĭlova EV; Val'dman EA; Nerobkova LN; Voronina TA; Avakian GN
Eksp Klin Farmakol; 2004; 67(2):16-8. PubMed ID: 15188753
[TBL] [Abstract][Full Text] [Related]
10. [The acute and subchronic effects of hemantane on [3H]-dopamine reuptake in rat striatal synaptosomes ex vivo].
Abaimov DA; Kovalev GI
Eksp Klin Farmakol; 2007; 70(4):11-4. PubMed ID: 18078034
[TBL] [Abstract][Full Text] [Related]
11. [Effect of a new antiparkinsonian drug himantane on monoamine oxidase activity].
Val'dman EA; Voronina TA; Aksenova LN; Buneeva OA; Medvedev AE
Eksp Klin Farmakol; 2003; 66(5):3-5. PubMed ID: 14650204
[TBL] [Abstract][Full Text] [Related]
12. The influence and the mechanism of docosahexaenoic acid on a mouse model of Parkinson's disease.
Ozsoy O; Seval-Celik Y; Hacioglu G; Yargicoglu P; Demir R; Agar A; Aslan M
Neurochem Int; 2011 Oct; 59(5):664-70. PubMed ID: 21736911
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of sleep-wakefulness structure in parkinsonian syndrome in rats induced by 1-methyl-4-phenyl-1,2,2,6-tetrahydropyridine and oxotremorine].
Gugutsidze DA; Nerobkova LN; Boronina TA
Biull Eksp Biol Med; 1989 Aug; 108(8):206-9. PubMed ID: 2804326
[TBL] [Abstract][Full Text] [Related]
14. [Effect of the new potential anti-Parkinson agent, hymantane, on levels of monoamines and their metabolites in rat striatum (a microdialysis study)].
Andiarzhanova EA; Val'dman EA; Kudrin VS; Raevskiĭ KS; Voronina TA
Eksp Klin Farmakol; 2001; 64(6):13-6. PubMed ID: 11871228
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of the capability of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and pyridine derivatives to evoke parkinsonism].
Lermontiva NN; Soliakov LS; Bachurin SO; Tkachenko SE; Serkova TP
Biull Eksp Biol Med; 1989 Jun; 107(6):699-701. PubMed ID: 2790166
[TBL] [Abstract][Full Text] [Related]
16. Neurotrophic and neurorescue effects of Echinacoside in the subacute MPTP mouse model of Parkinson's disease.
Zhao Q; Gao J; Li W; Cai D
Brain Res; 2010 Jul; 1346():224-36. PubMed ID: 20478277
[TBL] [Abstract][Full Text] [Related]
17. [Effects of hemantane on the main subtypes of dopamine receptors in the rat striatum ex vivo].
Abaimov DA; Zimin IA; Kovalev GI
Eksp Klin Farmakol; 2008; 71(1):18-21. PubMed ID: 18365481
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effects of echinacoside in the mouse MPTP model of Parkinson's disease.
Geng X; Tian X; Tu P; Pu X
Eur J Pharmacol; 2007 Jun; 564(1-3):66-74. PubMed ID: 17359968
[TBL] [Abstract][Full Text] [Related]
19. MPTP-induced parkinsonism: acceleration of biochemical and behavioral recovery by GM1 ganglioside treatment.
Schneider JS
J Neurosci Res; 1992 Jan; 31(1):112-9. PubMed ID: 1613817
[TBL] [Abstract][Full Text] [Related]
20. Beta and gamma range EEG power-spectrum correlation with spiking discharges in DBA/2J mice absence model: role of GABA receptors.
Marrosu F; Santoni F; Fà M; Puligheddu M; Barberini L; Genugu F; Frau R; Manunta M; Mereu G
Epilepsia; 2006 Mar; 47(3):489-94. PubMed ID: 16529610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
